Peale Chuang is a Nephrology physician. OpenAlex indexes 21 publications with 1,579 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3158 Freedom Dr Ste 3101
Charlotte, NC 282080014
Telephone
704-348-2992Provider last certified this registry record 6 Jul 2023.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20241 payment
- Bayer Healthcare Pharmaceuticals Inc.Program year20231 payment
- Travere Therapeutics, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
38.3%Beta blocker11%Carvedilol54%Metoprolol Tartrate19%Metoprolol Succinate18%Labetalol Hcl9%Part D<11 patientsCalcium channel blocker6.2%Amlodipine Besylate80%Nifedipine Er21%Part D≥45 patients+ 7 more classes in this area
Metabolism & gastrointestinal
28.1%Corticosteroid12.5%Prednisone100%Part D≥81 patientsH2 blocker6.6%Famotidine100%Part D≥31 patients+ 3 more classes in this area
Anti-infectives
22.2%Short-acting sulfonamides20.6%Sulfamethoxazole-Trimethoprim100%Part D≥89 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor1%Valganciclovir Hcl100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation
Journal of the American Society of Nephrology
2026 - Donor-derived cell-free DNA significantly improves rejection yield in kidney transplant biopsies
American Journal of Transplantation
2025 - Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial
Repository@Nottingham (University of Nottingham)
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”